Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000950170-25-110163

10% owner sold 260,713 shares at an average $39.34 ($10,255,244)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Versant Venture Capital VI, L.P. 10% owner 2025-08-15 Sale −145,051 $39.50 $5,729,515 1,430,848 D: show line 1 in the form
Versant Venture Capital VI, L.P. 10% owner 2025-08-15 Sale −69,949 $39.50 $2,762,986 977,963 I: show line 2 in the form
Versant Venture Capital VI, L.P. 10% owner 2025-08-18 Sale −30,628 $38.56 $1,181,049 1,400,220 D: show line 3 in the form
Versant Venture Capital VI, L.P. 10% owner 2025-08-18 Sale −15,085 $38.56 $581,694 962,878 I: show line 4 in the form
Open-market sales · 260,713 sh · avg $39.34 · $10,255,244
Loading xslF345X05/ownership.xml…